Chemokine-like factor-like MARVEL transmembrane domain-containing family in autoimmune diseases.
10.1097/CM9.0000000000000747
- Author:
Hong-Ji DUAN
1
;
Xin-Yi LI
;
Chang LIU
;
Xiao-Li DENG
Author Information
1. Department of Rheumatology and Immunology, Peking University Third Hospital, Beijing 100191, China.
- Publication Type:Journal Article
- From:
Chinese Medical Journal
2020;133(8):951-958
- CountryChina
- Language:English
-
Abstract:
The chemokine-like factor (CKLF)-like MARVEL transmembrane domain-containing family (CMTM) is widely expressed in the immune system. Abnormal expression of CMTM is associated with the development of various diseases. This article summarizes the relevant research on the role of the CMTM family in immune disorders. This information will increase our understanding of pathogenesis and identify promising targets for the diagnosis and treatment of autoimmune diseases. The CMTM family is highly expressed in peripheral blood mononuclear cells. CKLF1 may be involved in the development of arthritis through its interaction with C-C chemokine receptor 4. CKLF1 is associated with the pathogenesis of lupus nephritis and psoriasis. Both CMTM4 and CMTM5 are associated with the pathogenesis of systemic lupus erythematosus. CMTM1, CMTM2, CMTM3, and CMTM6 play a role in rheumatoid arthritis, systemic sclerosis, Sjögren syndrome, and anti-phospholipid syndrome, respectively. The CMTM family has been implicated in various autoimmune diseases. Further research on the mechanism of the action of CMTM family members may lead to the development of new treatment strategies for autoimmune diseases.